Curo Prime Pharmax Private Limited

Curo Prime Pharmax Private Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
CIN U24232RJ2008PTC025682 Incorporated 17 January 2008 ROC Jaipur HQ Jaipur, Rajasthan, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹1.07 Cr
▲ 15% YoY
Net profit · FY 2024
₹4.5 Lakh
Net margin 4.2%
EBITDA · FY 2024
₹10.96 Lakh
EBITDA margin 10.3%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹28.99 Lakh
Issued & subscribed
Open charges
₹12 Lakh
Satisfied ₹26 Lakh
Company age
18 yrs
Est. 2008
Directors on board
3
As per MCA filings

About Curo Prime Pharmax Private Limited

Data last updated:

Curo Prime Pharmax Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 January 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2008PTC025682. Its GSTIN is 08AADCC2627B1Z6 (Rajasthan).

The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹28.99 Lakh. It is led by directors including Sanjay Chamria and Kushagar Chamaria.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jaipur, Rajasthan.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.07 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹4.5 Lakh (net margin 4.2%) and EBITDA of ₹10.96 Lakh (EBITDA margin 10.3%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 3% over five years.

As per MCA filings, the company has open charges of ₹12 Lakh and satisfied charges of ₹26 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company.

Curo Prime Pharmax Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0073800). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232RJ2008PTC025682
Registration Number 025682
Incorporation Date 17 January 2008
ROC Jaipur
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0073800
Key People
Sanjay Chamria Director Kushagar Chamaria Director Ajay Gupta Director

Recognitions & Rankings of Curo Prime Pharmax

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-RJ-17-0073800

Contact details

Curo Prime Pharmax Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    G – 1 Plot No. 802 Rani Sati Nagar Bansi Path Nirman Naga, R, Jaipur, Rajasthan, India – 302019
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Curo Prime Pharmax Private Limited, buy the company report.

Comprehensive company report
Curo Prime Pharmax Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Curo Prime Pharmax is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Curo Prime Pharmax Private Limited, buy the company report.

Financials of Curo Prime Pharmax Private Limited

FY 2025 filings available

Curo Prime Pharmax Private Limited reported revenue of ₹1.07 Cr (up 15% YoY) for FY 2024.

Revenue · FY 2024
₹1.07 Cr ▲ 15%
Net profit · FY 2024
₹4.5 Lakh margin 4.2%
EBITDA · FY 2024
₹10.96 Lakh margin 10.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 3%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 31%
5 years · compounded
▲ 71%

Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 15% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.96 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹4.5 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin10.3%
Net Profit Margin4.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Curo Prime Pharmax Private Limited, buy the company report.

Board of directors of Curo Prime Pharmax Private Limited

Curo Prime Pharmax has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sanjay Chamria
Also directs: Apex Fibre India Limited
Director03 Apr 201016 Years 7 MonthsCurrent
Kushagar ChamariaDirector28 May 20224 Years 5 MonthsCurrent
Ajay GuptaDirector06 May 20224 Years 6 MonthsCurrent
View all directors

Peer comparison

Curo Prime Pharmax Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Trubeca Lifesciences Private Limited₹1.07 Cr (FY 2025)38.0%Zirakpur, Punjab, India
Oswald Pharmaceuticals Private Limited₹1.07 Cr (FY 2025)80.0%Bangalore, Karnataka, India
Curo Prime Pharmax Private Limitedthis company₹1.07 Cr (FY 2024)₹4.5 Lakh4.2%15.0%Jaipur, Rajasthan, India
Bionomics Lifesciences Private Limited₹1.06 Cr (FY 2022)87.0%Ambala Cantt, Haryana, India

To see the full peer comparison of Curo Prime Pharmax Private Limited, buy the company report.

Auditor

Curo Prime Pharmax Private Limited is audited by H M JOHARI & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
H M JOHARI & COFY 2019007227C

Shareholding

The shareholding of Curo Prime Pharmax Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Curo Prime Pharmax Private Limited, buy the company report.

Charges & borrowings

Open charges
₹12 Lakh
Satisfied charges
₹26 Lakh
Breakdown by lending institutions
Others₹0.12 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Dec 2023100844491Others₹12 LakhOpen
23 Jul 2021100464696Hdfc Bank Limited₹7 LakhSatisfied
30 Aug 2019100287519Others₹9 LakhSatisfied
06 Feb 2017100077494Others₹10 LakhSatisfied

To see the full charge records of Curo Prime Pharmax Private Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Curo Prime Pharmax Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Curo Prime Pharmax has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
08AADCC2627B1Z6RajasthanActive01 Jul 2017

To see the full GST registrations and return filing status of Curo Prime Pharmax Private Limited, buy the company report.

Recent activity

Curo Prime Pharmax Private Limited has 11 board changes on record since 2010: 3 appointments and 8 cessations. The latest: Vijander Gaur ceased to be Director on 03 Jun 2022.

AGM
Curo Prime Pharmax Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Curo Prime Pharmax Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge registered on 30 Aug 2019 via Charge ID 100287519 with Others was fully satisfied on 10 Oct 2024.
Charges
A charge registered on 23 Jul 2021 via Charge ID 100464696 with Hdfc Bank Limited was fully satisfied on 09 Oct 2024.
Charges
A charge registered on 06 Feb 2017 via Charge ID 100077494 with Others was fully satisfied on 09 Oct 2024.
Charges
A charge with Others amounted to Rs. 12.00 Lakh with Charge ID 100844491 was registered on 28 Dec 2023.
Ceased
Vijander Gaur ceased to be Director.
Appointed
Kushagar Chamaria was appointed as Director.
Appointed
Ajay Gupta was appointed as Director.
Ceased
Ajay Gupta ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.00 Lakh with Charge ID 100464696 was registered on 23 Jul 2021.
Charges
A charge with Others amounted to Rs. 9.00 Lakh with Charge ID 100287519 was registered on 30 Aug 2019.

9 earlier events are in the company report.

Frequently asked questions

Curo Prime Pharmax is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 January 2008 (18+ years old) and is registered under CIN U24232RJ2008PTC025682.

Curo Prime Pharmax has 3 current directors:

The latest financial statements of Curo Prime Pharmax on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Curo Prime Pharmax is 08AADCC2627B1Z6, registered in Rajasthan.

The CIN (Corporate Identification Number) of Curo Prime Pharmax is U24232RJ2008PTC025682. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Curo Prime Pharmax has 2 court cases on record: 2 filed by the company.

Curo Prime Pharmax was incorporated on 17 January 2008, making it 18+ years old. It is registered with the Registrar of Companies, Jaipur.

The peers of Curo Prime Pharmax by revenue are Trubeca Lifesciences Private Limited, Oswald Pharmaceuticals Private Limited, Bionomics Lifesciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Vijander Gaur ceased to be Director on 03 Jun 2022. Kushagar Chamaria was appointed as Director on 28 May 2022. Ajay Gupta was appointed as Director on 06 May 2022. Curo Prime Pharmax has 11 board changes on record in total.

Yes, Curo Prime Pharmax is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0073800).

The registered office of Curo Prime Pharmax is at G – 1 Plot No. 802 Rani Sati Nagar Bansi Path Nirman Naga, R, Jaipur, Rajasthan, India – 302019.